Guadecitabine
Previously Treated Metastatic Colorectal Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsSmall moleculePhase 1/2Dormant
CCC
52/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 37/ 100
- Competitive Position
- 95/ 100
Competitive context
0 Active assets in the Previously Treated Metastatic Colorectal Cancer cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
2-ACETYLFURO-1,4-NAPHTHOQUINONE 1Globe Health Institute LLC | Phase 3 | B |
Same molecule, other indications
Guadecitabine is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →